Danshen was able to reduce the risk of the patients with coronary heart disease (CHD), but the mechanism is still widely unknown. Biochemical indices (lipid profile, markers of renal and liver function, and homocysteine (Hcy)) are closely associated with CHD risk. We aimed to investigate whether the medicine reduces CHD risk by improving these biochemical indices. The patients received 10 Danshen pills (27 mg/pill) in Dashen group, while the control patients received placebo pills, three times daily. The duration of follow-up was three months. The serum biochemical indices were measured, including lipid profiles (LDL cholesterol (LDL-C), HDL-C, total cholesterol (TC), triglycerides (TG), apolipoprotein (Apo) A, ApoB, ApoE, and lipoprotein (a) (Lp(a))); markers of liver function (gamma-glutamyl transpeptidase (GGT), total bilirubin (TBil), indirect bilirubin (IBil), and direct bilirubin (DBil)); marker of renal function (uric acid (UA)) and Hcy. After three-month follow-up, Danshen treatment reduced the levels of TG, TC, LDL-C, Lp(a), GGT, DBil, UA, and Hcy (). In contrast, the treatment increased the levels of HDL-C, ApoA, ApoB, ApoE, TBil, and IBil (). Conclusion. Danshen can reduce the CHD risk by improving the biochemical indices of CHD patients.
from #Medicine via ola Kala on Inoreader http://ift.tt/1X5nPpb
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
▼
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
-
▼
Ιουνίου
(946)
-
▼
Ιουν 05
(30)
- A Plea for Ecological Argument Technologies
- Errors as a Means of Reducing Impulsive Food Choice
- Danshen (Salvia miltiorrhiza) Compounds Improve th...
- Vascular Protective Role of Samul-Tang in HUVECs: ...
- Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pa...
- Prevalence of Extended Spectrum β-Lactamase and An...
- Editorial Board
- Proteomics offers insight to the mechanism behind ...
- A multi-model statistical approach for proteomic s...
- In vitro evidence of the promoting effect of testo...
- Proteomic comparisons of venoms of long-term capti...
- Quantitative proteomics and phosphoproteomics of s...
- A Proteomic Road To Acquire An Accurate Serologica...
- Profiling the proteomics in honeybee worker brains...
- Species and tissues specific differentiation of pr...
- Metabolic profiling of potential lung cancer bioma...
- Modulating the endometrial epithelial proteome and...
- Chinese Herbal Medicine for Functional Abdominal P...
- Efficacy of Linezolid and Fosfomycin in Catheter-R...
- Formation of Aldehydic Phosphatidylcholines during...
- Subcritical Water Technology for Enhanced Extracti...
- Measuring functioning and disability after a disas...
- Influence of repetitive peripheral magnetic stimul...
- Discovery of new [1,4]dioxino[2,3-f]quinazoline-ba...
- Dihydrochelerythrine and its derivatives: Synthesi...
- Optimization of the phenylurea moiety in a phospho...
- Pyrazolylbenzo[d]imidazoles as new potent and sele...
- Editorial board
- Design, synthesis and biological evaluation of nov...
- Antiproliferative activity and apoptosis inducing ...
-
▼
Ιουν 05
(30)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Κυριακή 5 Ιουνίου 2016
Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.